{"2021-11-30": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Asian FX, stocks pare gains on Moderna CEO's Omicron warning - Reuters", "description": "Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean shares dropped over 2% on weak domestic data.", "url": "https://www.reuters.com/markets/stocks/asian-fx-stocks-pare-gains-moderna-ceos-omicron-warning-2021-11-30/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-11-30T08:02:00Z", "content": "Nov 30(Reuters) - Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean \u2026 [+2829 chars]"}], "2021-12-10": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Tesla, Southwest Airlines, Snap Inc, Moderna, SM Energy - Reuters", "description": "U.S. stock indexes rose on Friday after data showed consumer prices rose largely in line with estimates last month, taking some pressure off investors concerned about the Federal Reserve's aggressive tightening of its monetary policy.", "url": "https://www.reuters.com/markets/asia/tesla-southwest-airlines-snap-inc-moderna-sm-energy-2021-12-10/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=63", "publishedAt": "2021-12-10T15:55:00Z", "content": "U.S. stock indexes rose on Friday after data showed consumer prices rose largely in line with estimates last month, taking some pressure off investors concerned about the Federal Reserve's aggressive\u2026 [+2796 chars]"}], "2021-12-02": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Moderna may have Omicron booster by March | Reuters Video - Reuters.com", "description": "Moderna could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Fred Katayama reports.", "url": "https://www.reuters.com/video/watch/idOVF6COH3F", "urlToImage": "https://static.reuters.com/resources/r/?d=20211202&i=OVF6COH3F&r=OVF6COH3F&t=2", "publishedAt": "2021-12-02T16:54:12Z", "content": "Posted \r\nModerna could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Fred Kat\u2026 [+13 chars]"}], "2021-12-17": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "CDC panel recommends Pfizer, Moderna over J&J shot - Reuters", "description": "A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's shot, due to rare but sometimes fatal case\u2026", "url": "https://www.reuters.com/video/watch/idPBOo?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bbd0a4e4b09631b0e445ba-1639698596092?location=LANDSCAPE", "publishedAt": "2021-12-17T00:11:20Z", "content": "Posted \r\nA panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccine\u2026 [+92 chars]"}], "2021-12-20": [{"source": {"id": null, "name": "NPR"}, "author": "Jaclyn Diaz", "title": "Moderna says its COVID booster increases protection against omicron", "description": "Moderna said its current FDA-approved 50-microgram booster shot increased antibody levels against omicron 37-fold compared to pre-booster levels.", "url": "https://www.npr.org/2021/12/20/1065734884/moderna-says-its-covid-booster-increases-protection-against-omicron", "urlToImage": "https://media.npr.org/assets/img/2021/12/20/ap21350469730902_wide-0d598730107da05c19468e3d800be749c0460327.jpg?s=1400", "publishedAt": "2021-12-20T11:11:33Z", "content": "Moderna said Monday preliminary data showed its COVID-19 booster shot is effective against the omicron variant of the coronavirus currently surging in the U.S. and around the world.\r\nThe pharmaceutic\u2026 [+904 chars]"}], "2021-12-23": [{"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition", "description": "Moderna's (MRNA) COVID-19 vaccine may face stiffer competition following the FDA's emergency approval of an oral COVID-19 pill, Pfizer's Paxlovid, which may result in lower sales.", "url": "http://www.zacks.com/stock/news/1842878/moderna-mrna-down-as-pfizer-paxlovid-eua-may-fuel-competition?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842878", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404475.jpeg", "publishedAt": "2021-12-23T15:39:00Z", "content": "Shares of popular COVID-19 vaccine-maker, ModernaMRNA were down 6.3% on Wednesday, following the news of emergency use authorization (EUA) for Pfizers PFE promising oral COVID-19 pill, Paxlovid, in t\u2026 [+7367 chars]"}], "2021-12-22": [{"source": {"id": null, "name": "Tbnewswatch.com"}, "author": "Leith Dunick", "title": "Health unit switching to mainly Moderna vaccines - Tbnewswatch.com", "description": "Health unit switching to mainly Moderna vaccines\u00a0\u00a0Tbnewswatch.comView Full coverage on Google News", "url": "https://www.tbnewswatch.com/coronavirus-covid-19-local-news/health-unit-switching-to-mainly-moderna-vaccines-4893157", "urlToImage": "https://www.vmcdn.ca/f/files/townandcountrytoday/images/moderna-vaccine.jpg;w=1200;h=800;mode=crop", "publishedAt": "2021-12-22T23:30:00Z", "content": "THUNDER BAY -- The Thunder Bay District Health Unit is switching to Moderna'sSpikeVax as its primary vaccine moving forward.\r\nThe health unit on Wdnesday said the move will be made mainly due to supp\u2026 [+1390 chars]"}], "2021-12-06": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Reuters", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response-uk-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/2hWWuQQtDAfsE2_em2jdEEeltMw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/P3XCTOZZEJKGRERRQ6XNXOCXUU.jpg", "publishedAt": "2021-12-06T23:40:00Z", "content": "Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots follow\u2026 [+3422 chars]"}], "2021-12-01": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna exec says company could have Omicron booster ready in March - Reuters", "description": "Moderna Inc <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wedn\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-exec-says-company-could-have-omicron-booster-ready-march-2021-12-01/", "urlToImage": "https://www.reuters.com/resizer/V-emukdLzpodyAgK9a6EjkNy6bU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZIV5R25AABINFPNCMEOPSZQP7U.jpg", "publishedAt": "2021-12-01T19:56:00Z", "content": "NEW YORK, Dec 1 (Reuters) - Moderna Inc (MRNA.O) could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's presi\u2026 [+3401 chars]"}], "2021-12-16": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer - Reuters", "description": "Japan on Thursday officially approved Moderna Inc's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine for its booster shot programme that began this month.", "url": "https://www.reuters.com/world/asia-pacific/japan-adds-moderna-shot-covid-vaccine-booster-arsenal-joining-pfizer-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/DNWCKjP-UTc21x4Fij5lqVdfy-U=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LXZ7Q7HUERO4LJ6MQSEN5X7GLE.jpg", "publishedAt": "2021-12-16T03:19:00Z", "content": "TOKYO, Dec 16 (Reuters) - Japan on Thursday officially approved Moderna Inc's (MRNA.O) COVID-19 vaccine for its booster shot programme that began this month.\r\nThe move followed a recommendation from \u2026 [+1316 chars]"}], "2021-12-21": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna could be ready to develop Omicron booster in weeks - CEO - Reuters", "description": "COVID-19 vaccine maker Moderna <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin work in a few we\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-could-be-ready-develop-omicron-booster-weeks-ceo-2021-12-21/", "urlToImage": "https://www.reuters.com/resizer/vFCsqhKPg-HAAWgX-qlg38-H9mk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/L7LSITQGFBJWLHA756XMPIQYCU.jpg", "publishedAt": "2021-12-21T07:42:00Z", "content": "ZURICH, Dec 21 (Reuters) - COVID-19 vaccine maker Moderna (MRNA.O) does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin \u2026 [+2619 chars]"}], "2022-01-04": {"status": "ok", "totalResults": 2, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Alex Carchidi and Taylor Carmichael)", "title": "Better Buy: Novavax vs. Moderna", "description": "Both of these coronavirus vaccine innovators have plenty of upside in 2022.", "url": "https://www.fool.com/investing/2022/01/04/better-buy-novavax-vs-moderna/", "urlToImage": "https://g.foolcdn.com/editorial/images/659510/worker-holds-coronavirus-vaccine-syringe.jpg", "publishedAt": "2022-01-04T11:08:00Z", "content": "Novavax(NASDAQ:NVAX) and Moderna(NASDAQ:MRNA) are two of the biotech industry's biggest success stories from the coronavirus vaccine race. While Moderna's market cap of around $104 billion makes Nova\u2026 [+5313 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Tomi Kilgore", "title": "Moderna shipped 800 million COVID vaccines last year, more than tripled its cash position but stock falls again", "description": "Moderna Inc. said in a letter to shareholders disclosed Tuesday, Chief Executive St\u00e9phane Bancel said the biotechnology company had shipped about 800 million doses of its COVID-19 vaccine to more than 60 countries in 2021, and more than tripled the amount of \u2026", "url": "https://www.marketwatch.com/story/moderna-shipped-800-million-covid-vaccines-last-year-more-than-tripled-its-cash-position-but-stock-falls-again-2022-01-04", "urlToImage": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "publishedAt": "2022-01-04T13:22:50Z", "content": "Moderna Inc. \r\n MRNA,\r\n -7.45%\r\nsaid in a letter to shareholders disclosed Tuesday, Chief Executive St\u00e9phane Bancel said the biotechnology company had shipped about 800 million doses of its COVID-19 \u2026 [+1133 chars]"}]}, "2022-01-03": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Interval between Moderna COVID-19 vaccine second shot and booster still six months -FDA - Reuters", "description": "The interval between receiving a second dose of Moderna's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine and a booster dose remains unchanged at six months, U.S. Food and Drug Administration Acting Commissione\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/interval-between-moderna-covid-19-vaccine-second-shot-booster-still-six-months-2022-01-03/", "urlToImage": "https://www.reuters.com/resizer/vFCsqhKPg-HAAWgX-qlg38-H9mk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/L7LSITQGFBJWLHA756XMPIQYCU.jpg", "publishedAt": "2022-01-03T16:53:00Z", "content": "A pharmacist holds a vial of the Moderna coronavirus disease (COVID-19) vaccine in West Haven, Connecticut, U.S., February 17, 2021. REUTERS/Mike SegarWASHINGTON, Jan 3 (Reuters) - The interval betwe\u2026 [+703 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Pfizer, BioNTech, and Moderna Stocks Are Falling Today", "description": "Investors appear to be seeing a future where COVID-19 vaccines aren't needed nearly as much.", "url": "https://www.fool.com/investing/2022/01/03/why-pfizer-biontech-and-moderna-stocks-are-falling/", "urlToImage": "https://g.foolcdn.com/editorial/images/659670/vaccine-being-given-to-a-young-man.jpg", "publishedAt": "2022-01-03T17:01:00Z", "content": "What happened\r\nShares of several leading COVID-19 vaccine makers were falling as of 11:38 a.m. ET on Monday. Pfizer(NYSE:PFE) stock was down 3.5%. Shares of BioNTech(NASDAQ:BNTX) and Moderna(NASDAQ:M\u2026 [+2692 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-omicron-pfizer-moderna-astrazeneca-b1985766.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-03T07:26:31Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "ACCESSWIRE", "title": "Moderna to Provide Business and Pipeline Updates at the 2022 J.P. Morgan Healthcare Conference", "description": "CAMBRIDGE, MA / ACCESSWIRE / January 3, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...", "url": "https://finance.yahoo.com/news/moderna-business-pipeline-updates-2022-153000994.html", "urlToImage": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png", "publishedAt": "2022-01-03T15:30:00Z", "content": "CAMBRIDGE, MA / ACCESSWIRE / January 3, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO St\u00e9phane Bancel\u2026 [+2094 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Tech Stock Pros", "title": "Moderna: Time To Hop Off The Pandemic Train. Looming Revenue Declines To Pressure The Stock", "description": "Moderna developed one of the three vaccines approved in the U.S. to prevent COVID-19. Read more to see why I think it's time to take profits at this valuation.", "url": "https://seekingalpha.com/article/4477633-moderna-time-to-hop-off-pandemic-train-looming-revenue-declines-to-pressure-the-stock", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303673692/large_image_1303673692.jpg", "publishedAt": "2022-01-03T07:08:50Z", "content": "carmengabriela/iStock Editorial via Getty Images\r\nModerna Inc. (NASDAQ:MRNA), a clinical-stage biotechnology company, develops therapeutics and vaccines based on messenger RNA to treat infectious and\u2026 [+6101 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna COVID booster FAQ: When can you get a third dose?", "description": "The FDA just reduced the waiting period for COVID-19 vaccine boosters -- including Moderna's Spikevax -- but when and where can you get it and what are the side effects?", "url": "https://www.cnet.com/health/moderna-covid-booster-faq-side-effects-when-can-i-get/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2022-01-03T19:22:17Z", "content": "New research shows the Moderna vaccine to be the most effective booster.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO an\u2026 [+11439 chars]"}]}, "2022-01-02": {"status": "ok", "totalResults": 3, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/vaccines-protection-omicron-pfizer-moderna-astrazeneca-b1985492.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2022-01-02T09:51:39Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna COVID booster FAQ: Side effects, vaccine effectiveness, what to know about third dose - CNET", "description": "Get the latest on Moderna's COVID-19 booster shot and its fight against the omicron variant.", "url": "https://www.cnet.com/health/moderna-covid-booster-faq-side-effects-vaccine-effectiveness-what-to-know-about-third-dose/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2022-01-02T21:30:03Z", "content": "New research shows the Moderna vaccine to be the most effective booster.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO an\u2026 [+11815 chars]"}, {"source": {"id": null, "name": "TheJournal.ie"}, "author": "Aoife Barry", "title": "Sitdown Sunday: Dolly Parton on donating money to the Moderna vaccine", "description": "Settle back in a comfy chair and sit back with some of the week\u2019s best longreads.", "url": "https://www.thejournal.ie/sitdown-sunday-longreadas-5641676-Jan2022/", "urlToImage": "https://img2.thejournal.ie/article/5641676/river/?height=400&version=5643854", "publishedAt": "2022-01-02T09:00:12Z", "content": "ITS A DAY of rest, and you may be in the mood for a quiet corner and a comfy chair.\r\nWeve hand-picked the weeks best reads for you to savour.\r\n1. Hello Dolly\r\nAn interview with the one and only Dolly\u2026 [+5561 chars]"}]}, "2022-01-01": {"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna booster FAQ: COVID shot side effects, vaccine effectiveness, what to know about third dose", "description": "A COVID-19 booster shot is a critical piece in the fight against the omicron variant.", "url": "https://www.cnet.com/health/moderna-booster-faq-covid-shot-side-effects-vaccine-effectiveness-what-to-know-about-third-dose/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2022-01-01T17:06:00Z", "content": "The Moderna COVID-19 booster shots contain a half-dose of the vaccine.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and \u2026 [+11808 chars]"}]}, "2021-12-31": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Bre Bradham", "title": "Moderna Stock Volatility Leads to Worst Month in Turbulent Year", "description": "(Bloomberg) -- It\u2019s been a wild ride for Moderna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the...", "url": "https://finance.yahoo.com/news/moderna-stock-volatility-leads-worst-174741766.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/CCzZ4HaagGRcfiOeXL2JTw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/a755b5019fecc550cc398df1f188ba17", "publishedAt": "2021-12-31T17:47:41Z", "content": "(Bloomberg) -- Its been a wild ride for Moderna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the Covid-19 vaccine maker.\r\nMost Read from Bloo\u2026 [+2471 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "The Associated Press", "title": "Moderna, Signature bank rise; GameStop, PayPal fall", "description": "Stocks that traded heavily or had substantial price changes Friday: Moderna, Signature bank rise; GameStop, PayPal fall", "url": "https://abcnews.go.com/Business/wireStory/moderna-signature-bank-rise-gamestop-paypal-fall-82024667", "urlToImage": "null", "publishedAt": "2021-12-31T21:53:45Z", "content": "Stocks that traded heavily or had substantial price changes Friday:\r\nModerna, up $2.38 to $253.98\r\nThe vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\r\nAdv\u2026 [+848 chars]"}, {"source": {"id": null, "name": "Minneapolis Star Tribune"}, "author": "Star Tribune Staff", "title": "Moderna, Signature bank rise; GameStop, PayPal fall", "description": "Stocks that traded heavily or had substantial price changes Friday:", "url": "https://www.startribune.com/moderna-signature-bank-rise-gamestop-paypal-fall/600131700/", "urlToImage": "https://assets.startribune.com/static/img/branding/logos/strib-social-card.png?d=1640904844", "publishedAt": "2021-12-31T21:53:00Z", "content": "Stocks that traded heavily or had substantial price changes Friday:\r\nModerna, up $2.38 to $253.98\r\nThe vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\r\nAdv\u2026 [+850 chars]"}, {"source": {"id": null, "name": "seattlepi.com"}, "author": null, "title": "Moderna, Signature bank rise; GameStop, PayPal fall", "description": "Stocks that traded heavily or had substantial price changes Friday:\nModerna, up $2.38 to $253.98\nThe vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\nAdvanced Micro Devices, down $1.25 to $143.90\nThe company said it \u2026", "url": "https://www.seattlepi.com/business/article/Moderna-Signature-bank-rise-GameStop-PayPal-16741022.php", "urlToImage": "https://www.seattlepi.com/img/pages/article/opengraph_default.png", "publishedAt": "2021-12-31T22:06:03Z", "content": "The vaccine maker rose as cases of the omicron variant of COVID-19 continued to spread quickly.\r\nAdvanced Micro Devices, down $1.25 to $143.90\r\nThe company said it was making progress on getting regu\u2026 [+749 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Breanna Bradham", "title": "Moderna Stock Volatility Leads to Worst Month in Turbulent Year - Bloomberg", "description": "It\u2019s been a wild ride for Moderna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the Covid-19 vaccine maker.", "url": "https://www.bloomberg.com/news/articles/2021-12-31/moderna-stock-volatility-leads-to-worst-month-in-turbulent-year", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/irE4fmnkemsU/v2/1200x675.png", "publishedAt": "2021-12-31T17:47:41Z", "content": "Its been a wild ride for \r\nModerna Inc. with its shares on pace for their biggest monthly decline this year as investor optimism wanes on the Covid-19 vaccine maker.\r\nModerna has slumped 27% in a mon\u2026 [+298 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna booster: UK says Moderna tops Pfizer in protection against omicron", "description": "COVID-19 boosters shots have become essential in the fight against the omicron variant. New stats support Moderna as the best choice.", "url": "https://www.cnet.com/health/moderna-booster-uk-stats-show-moderna-tops-pfizer-in-protection-against-omicron/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2021-12-31T19:00:03Z", "content": "The Moderna COVID-19 booster shots contain a half-dose of the vaccine.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and \u2026 [+13060 chars]"}]}, "2021-12-30": {"status": "ok", "totalResults": 4, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Pfizer, BioNTech, and Moderna Shot Higher Today", "description": "One coronavirus vaccine will apparently be authorized as a booster for younger people in the U.S.", "url": "https://www.fool.com/investing/2021/12/30/why-pfizer-biontech-and-moderna-shot-higher-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/659417/gloved-hand-filling-a-syringe-from-a-vial.jpg", "publishedAt": "2021-12-30T23:15:43Z", "content": "What happened\r\nThree of the top coronavirus stocks, Pfizer(NYSE:PFE), BioNTech(NASDAQ:BNTX), and Moderna(NASDAQ:MRNA), saw plenty of action on the market Thursday. Encouraging news for Pfizer and Bio\u2026 [+1502 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Moderna COVID booster: Does it work better than Pfizer's vaccine? - CNET", "description": "Booster shots have become critical in the fight against the omicron variant of COVID-19. How effective is Moderna's booster?", "url": "https://www.cnet.com/health/moderna-covid-booster-does-it-work-better-than-pfizers-vaccine/", "urlToImage": "https://www.cnet.com/a/img/KsQnO_TW5CSGlvHr4QRxSozaLR4=/1200x630/2021/01/29/d65517e9-b8b5-4ae4-a555-9d54d2388431/005-double-mask-recommendations-new-mandate-n95-kn95-cloth-medical-masks-face.jpg", "publishedAt": "2021-12-30T18:00:10Z", "content": "Moderna reports a 37-fold increase in \"omicron-neutralizing antibodies\" for those receiving the half-dose booster.\r\nAlgi Febri Sugita/Getty Images\r\nFor the most up-to-date news and information about \u2026 [+12642 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Study of Pfizer & Moderna vaccines against Omicron shows they have NEGATIVE effectiveness!", "description": null, "url": "https://www.investmentwatchblog.com/study-of-pfizer-moderna-vaccines-against-omicron-shows-they-have-negative-effectiveness/", "urlToImage": null, "publishedAt": "2021-12-30T14:02:21Z", "content": "I kid you not, the last line of the study is still these findings highlight the need for massive rollout of vaccinations and booster vaccinations.\r\n\u2014 Ezra Levant (@ezralevant) December 23, 2021\r\nSHOC\u2026 [+118 chars]"}, {"source": {"id": null, "name": "PRNewswire"}, "author": null, "title": "Thinking about trading options or stock in Alibaba, Advanced Micro Devices, Moderna, Walmart, or Dollar General?", "description": "NEW YORK, Dec. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, AMD, MRNA, WMT, and DG. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas\u2026", "url": "https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-alibaba-advanced-micro-devices-moderna-walmart-or-dollar-general-301451928.html", "urlToImage": "https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg?p=facebook", "publishedAt": "2021-12-30T15:57:00Z", "content": "NEW YORK, Dec. 30, 2021 /PRNewswire/ --\u00a0InvestorsObserver\u00a0issues critical PriceWatch Alerts for BABA, AMD, MRNA, WMT, and DG.\r\nClick a link below then choose between in-depth options trade idea repor\u2026 [+796 chars]"}]}, "2021-12-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-12-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}}